Skip to main content
Log in

Furosemide-induced tubular dysfunction responding to prostaglandin synthesis inhibitor therapy in a child with nephrotic syndrome

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

Furosemide is one of the most common drug used to treat anasarca in childhood nephrotic syndrome. It has minimal side effects on short-term usage, but prolonged use can result in polyuria, hypokalemia and metabolic alkalosis. This pseudo-bartter complication can be treated by discontinuation of the drug with adequate potassium replacement. We report a child who was given furosemide for 20 days elsewhere to treat the edema due to nephrotic syndrome and then presented to us with bartter-like syndrome. Furosemide was discontinued and potassium replacement was initiated. However, the child continued to have polyuria leading to repeated episodes of hypotensive shock. In view of severe symptoms, she was given a short course of oral indomethacin for 6 days, to which she responded. This case highlights the fact that indomethacin can provide symptomatic improvement in furosemide induced pseudo-bartter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Keller E, Hoppe-Seyler G, Schollmeyer P. Disposition and diuretic effect of furosemide in the nephritic syndrome. Clin Pharmacol Ther. 1982 32(4):442–9.

    Article  CAS  Google Scholar 

  2. Rane A, Villeneuve JP, Stone WJ, Nies AS, Wilkinson GR, Branch RA. Plasma binding and disposition of furosemide in the nephritic syndrome and in uremia. Clin Pharmacol Ther 1978; 24(2):199–207.

    Article  CAS  Google Scholar 

  3. Colussi G, Rombolà G, Airaghi C, De Ferrari ME, Minetti L. Pseudo-Bartter’s syndrome from surreptitious diuretic intake: differential diagnosis with true Bartter’s syndrome. Nephrol Dial Transpl. 1992;7:896–901.

    Article  CAS  Google Scholar 

  4. Numabe A, Ogata A, Abe M, Takahashi M, Kono K, Arakawa M, Ishimitsu T, Ieiri T, Matsuoka H, Yagi S. A case of pseudo-Bartter’s syndrome induced by long-term ingestion of furosemide delivered orally through health tea. Nihon Jinzo Gakkai Shi. 2003;45:457–63.

    PubMed  Google Scholar 

  5. Vasudevan A, Mantan M, Bagga A. Management of edema in nephrotic syndrome. Indian Pediatr. 2004;41(8):787 – 95.

    PubMed  Google Scholar 

  6. Schepkens H, Hoeben H, Vanholder R, Lameire N. Mimicry of surreptitious diuretic ingestion and the ability to make a genetic diagnosis. Clin Nephrol. 2001;55:233–7.

    CAS  PubMed  Google Scholar 

  7. Ruisz, et al. Furosemide-induced severe hypokalemia with rhabdomyolysis without cardiac arrest. BMC Women’s Health. 2013;13:30.

    Article  CAS  Google Scholar 

  8. Unwin RJ, Capasso G. Bartter’s and Gitelman’s syndromes: their relationship to the actions of loop and thiazide diuretics. Curr Opin Pharmacol. 2006;6:208–13.

    Article  CAS  Google Scholar 

  9. Kammerl MC, Nüsing RM, Richthammer W, Krämer BK, Kurtz A. Inhibition of COX-2 counteracts the effects of diuretics in rats. Kidney Int. 2001;60(5):1684–91.

    Article  CAS  Google Scholar 

  10. Sasaki H, Kawasaki T, Yamamoto T, Ninomiya H, et al. Pseudo-Bartter’s syndrome induced by surreptitious ingestion of furosemide to lose weight: a case report and possible pathophysiology. Nihon Naibunpi Gakkai Zasshi. 1986;62(8):867–81.

    CAS  PubMed  Google Scholar 

  11. Sasaki H, Okumura M, Kawasaki T, Kangawa K, Matsuo H. Indomethacin and atrial natriuretic peptide in pseudo-Bartter’s syndrome. N Engl J Med. 1987;316(3):167

    CAS  PubMed  Google Scholar 

  12. Seyberth HW, Koniger SJ, Rascher W, Kuhl PG, Schweer H. Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders. Pediatr Nephrol. 1987;1:491–7.

    Article  CAS  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karalanglin Tiewsoh.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Research involving human participants and/or animals

Due permission from the Departmental Review Board was taken.

Informed consent

Taken.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Varma, T.H., Sharma, A., Santhiya, S. et al. Furosemide-induced tubular dysfunction responding to prostaglandin synthesis inhibitor therapy in a child with nephrotic syndrome. CEN Case Rep 7, 195–197 (2018). https://doi.org/10.1007/s13730-018-0324-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-018-0324-3

Keywords

Navigation